SUMATRIPTAN 6MG/0.5ML
ID: 36C77025Q0171Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs is seeking to procure SUMATRIPTAN 6MG/0.5ML injection syringes, specifically packaged as two syringes per package, for delivery to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities. This procurement, identified under Solicitation Number 36C77025Q0171, is classified as unrestricted and emphasizes the importance of timely delivery of essential medications to veterans, ensuring compliance with all relevant regulations, including the requirement for a state wholesale distributor license. Interested vendors must submit their quotes, along with the necessary documentation, via email by March 29, 2025, following the issuance of the solicitation on March 13, 2025. For further inquiries, vendors can contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov, with the latter also reachable by phone at 913-684-0156.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Veterans Affairs seeks urgent procurement of various pharmaceuticals for delivery to multiple CMOP facilities. This acquisition, detailed in Solicitation Number 36C77025Q0171, is classified as UNRESTRICTED and is scheduled for issuance on March 13, 2025, with quotes due by March 29, 2025. Each vendor must ensure compliance with relevant regulations, including providing a state wholesale distributor license and filling out a detailed price schedule in Excel format. Preference is given to U.S.-made products, and all communications regarding changes to the solicitation will be posted on Contract Opportunities (sam.gov). Vendors must submit their quotes, inclusive of required documentation, via email. This requirement signifies the VA's commitment to ensuring that veterans receive essential medications promptly and efficiently across designated locations, adhering to legal and quality standards throughout the procurement process.
    Lifecycle
    Title
    Type
    SUMATRIPTAN 6MG/0.5ML
    Currently viewing
    Presolicitation
    Similar Opportunities
    SUMATRIPTAN 6MG/0.5ML
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to supply Sumatriptan 6mg/0.5ml injection syringes, specifically packaged as two syringes per package, for use in treating certain types of headaches. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA), necessitating that suppliers provide documentation such as a state wholesale distributor license along with their quotes. This solicitation is critical for ensuring the availability of essential pharmaceutical supplies to veterans, with the RFQ (36C77025Q0171) set to be issued on March 13, 2025, and closing on March 19, 2025, at 5:00 PM CST. Interested vendors should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details and to ensure compliance with all regulatory requirements.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0180 762-25-2-040-1379 -Tucson CMOP LURASIDONE
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to supply Lurasidone HCL 20mg tablets in 30-count bottles for the Tucson CMOP facility under solicitation number 36C77025Q0180. The procurement aims to fulfill a standard requirement for essential pharmaceuticals, emphasizing compliance with the Buy American statute and the Drug Supply Chain Security Act (DSCSA). This opportunity is critical for ensuring that veterans receive necessary medications in a timely manner, with a delivery timeframe of 10 days after receipt of order. Interested vendors must submit their quotes, including a signed SF1449 cover page, price schedule in Excel format, and a completed Buy American Certificate, to Michael W McAlhaney at Michael.McAlhaney@va.gov by March 19, 2025, with an estimated award date of March 24, 2025.
    Pharmaceuticals for Leavenworth CMOP
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply nine pharmaceuticals for delivery to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) in Kansas. This procurement, categorized under Solicitation Number 36C77025Q0173, includes medications such as Nitroglycerin ointment, Ondansetron tablets, and Pioglitazone tablets, with specific quantities and packaging requirements outlined in the solicitation. The pharmaceuticals are essential for providing necessary medical treatments to veterans, reflecting the VA's commitment to maintaining a reliable supply chain for critical medications. Interested vendors must submit their quotations via email by March 25, 2025, and ensure compliance with the Drug Supply Chain Security Act, with the estimated issue date for the solicitation being March 14, 2025. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--Aprepitant Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0029 concerning the procurement of Aprepitant Capsules, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. Offerors are required to provide a unique National Drug Code (NDC) number and ensure that their label is the sole representation on the product, with the contract set for one year plus four optional annual extensions. This procurement is critical for serving veterans and other federal health care facilities, with substantial estimated annual requirements for Aprepitant in various dosages. Interested parties should note that the solicitation will be released around March 25, 2025, with a closing date of April 8, 2025, and are encouraged to contact Matthew Poulin at matthew.poulin@va.gov for inquiries.
    Sources Sought Notice -ZOLPIDEM 12.5MG AND 6.25MG
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential vendors for the supply of Zolpidem Tartrate tablets in 12.5 mg and 6.25 mg dosages, each in 100-count packages, intended for distribution through the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This Request for Information (RFI) aims to gather insights on qualified sources capable of fulfilling these pharmaceutical requirements, emphasizing the need for vendors to confirm their licensing, registration with SAM.gov, and, if applicable, their status as a Service-Disabled Veteran-Owned Small Business (SD/VOSB) in VETCERT. The procurement process is in its preliminary stages, and responses will assist the VA in assessing marketplace capabilities without committing to a contract or incurring costs. Interested parties should submit their responses via email to Larry Zaritz at larry.zaritz@va.gov by 10:00 AM CST on February 7, 2025.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Fludrocortisone Acetate 0.1MG Tablets, packaged in bottles of 100 tablets, to ensure a reliable supply for various federal entities, including the Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to award a single contract that covers an initial term of one year, with the option for four additional one-year periods, thereby securing an uninterrupted source of this essential medication. The estimated annual requirement for the tablets is 31,127 bottles, and interested suppliers must provide a unique NDC or UPC number along with the product name as it appears on the label. The solicitation is expected to be published on or around March 28, 2025, with proposals due by April 11, 2025; inquiries can be directed to Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.
    6505--Loperamide Capsules (VA-25-00032225)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Loperamide HCL 2MG Capsules under Request for Proposal (RFP) 36E79725R0025. This procurement aims to ensure a consistent supply of the medication not only for the VA but also for the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), with the intention to award one contract that spans one year with four optional one-year extensions. The estimated requirements include 18,690 bottles of 100 capsules and 47,289 bottles of 500 capsules annually, reflecting the importance of maintaining a steady supply of essential medications for healthcare facilities. Interested parties should note that the solicitation is expected to be electronically issued by April 17, 2025, with responses due by May 1, 2025; inquiries can be directed to Contracting Officer Andrew Cazares at Andrew.Cazares@va.gov or (719) 786-4990.
    6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
    Leavenworth CMOP 11 PHARMACEUTICALS
    Buyer not available
    The Department of Veterans Affairs is seeking interest from potential contractors for the supply of domestically manufactured pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) program, as outlined in the Sources Sought Notice 36C77025Q0183. The VA is specifically looking for responses from both small and large pharmaceutical manufacturers and distributors capable of providing a specified list of medications, including Galantamine Hydrobromide and Hydrocortisone Ointment, among others. This initiative is crucial for ensuring a reliable pharmaceutical supply chain for veterans’ healthcare, aligning with Federal Acquisition Regulations to foster early dialogue about acquisitions. Interested parties must submit their responses to Sarah Fry at sarah.fry2@va.gov by March 18, 2025, as this is an information-gathering activity without any contractual obligations.